Third International Conference on Quality in Medicine, Global Health and Law
The Role of Interprofessional Collaboration in Improving Quality of Care in the Time of Pandemic
The discipline of quality management plays an essential role in effective functioning of the healthcare organizations. The first formal initiatives in this field were undertaken in Western Europe, Japan and the United States in the early 1970s, inspired by the quality control methods used in the manufacturing industry. Nowadays, hundreds of governmental agencies, non-profit, and community organizations around the world pursue research and implementation of various healthcare quality monitoring and improvement programs.
The first healthcare quality management initiatives undertaken in Poland in the early 1990s by the Polish Ministry of Health, resulted in the creation of the National Society for Quality Management in Healthcare in 1993, and in the establishment of the National Center for Healthcare Quality Monitoring in Krakow in 1994. The Center provides an essential administrative infrastructure for the training and accreditation purposes in the field of healthcare quality monitoring in Poland. Nevertheless, an ongoing training of healthcare professionals in various aspects of quality management is necessary. It can be effectively accomplished through the international collaboration encouraging the exchange of research results and ideas.
The goal of the annual conferences on Quality in Medicine, Global Health and Law held at the Scientific Center of the Polish Academy of Sciences in Paris, France, is to facilitate such collaboration among healthcare organizations and academic centers in Poland and the United States as well as other countries around the globe.
After a productive and inspiring Roundtable Meeting on Quality Improvement in Medicine held at the PAN Paris Scientific Center in April 2018, the Second PAN Paris International Conference on Quality Improvement in Medicine was held on May 15 and 16, 2019, and was focused on the role of international collaboration in improving quality of care. Programs and reports from the 2018 and 2019 conferences are available here:
The goal of the third PAN Paris Conference on Quality in Medicine, Global Health and Law, scheduled for May 17-19, 2021, is to explore the role of interprofessional collaboration in improving quality of care in the time of the current pandemic. The invited speakers will represent academic, governmental, corporate, and academic entities in Poland, the United States, as well as other countries in Europe, Africa, Asia, and the Americas.
Day 1: Alicia Ely Yamin
Pandemic – Global Perspective: An Inflection Point for Global Health and Human Rights
Alicia Ely Yamin is currently a Lecturer on Law and Senior Fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School; and Senior Advisor on Human Rights at the global health justice organization, Partners In Health (PIH).
In 2016, the UN Secretary General appointed Yamin as one of ten international global health experts to the Independent Accountability Panel for Women’s, Children’s and Adolescents’ Health in the Sustainable Development Goals. She currently serves on the WHO’s Technical Advisory Group on Health Technology Assessments, as well as the Lancet Commission on Arctic Health and the Expert Working Group on Global Public Investment. Yamin regularly provides expert testimony and guidance to national and supra-national tribunals and legislative bodies around the globe, in relation to the application of international and constitutional law to health issues.
Trained in both law and public health at Harvard, Yamin’s 25+-year career at the intersection of global health and human rights has bridged academia and activism, as well as law and global health/development. Yamin has lived and worked in Latin America and East Africa for half of her professional life, working with and through local advocacy organizations.
Day 2: Etienne Minvielle
Pandemic – French Perspective
Etienne Minvielle received his MD from the Paris V School of medicine where he did his residency in Public Health. He also received a PhD in Management Science from the Polytechnique School, and also be graduated from the French business school, ESSEC. He spent one year at the Leonard Davis Institute, University of Pennsylvania, during his post-doctoral period. He recently became the director of the Master of Science in Health Care Management (EHESP, AP-HP, Ecole du Santé des Armées, Paris VII). His research seeks to understand the effect of new delivery systems (new forms of payment, patient pathways, quality improvement incentives, customized service) on healthcare performance. He has been continuously funded by the French Ministry of Health and the High Authority for Health for developing a national quality program, including quality indicators, ranking methods and paying for quality system, since 2003. He is currently the principal investigator of a cancer navigation research supported by the French Agency for Research which assesses the impact of patient portal on oral drugs’ observance. He is also the coordinator of a study sponsored by the French Agency for Health care Performance for designing a composite score of hospital performance (based on the medico-administrative database named Hospidiag). His research has been published in high-impact peer-reviewed journals (The BMJ, NEJM catalyst, Medical Care, Social Science and Medicine, Public Administration Review, Health Policy). He also published The Quality Imperative (Imperial College Press) with John Kimberly (Wharton School), and recently “Le patient et le Système” (Ed. Seli Arslan). He serves on numerous expert panels advising policy makers and government officials on the use of quality improvement incentives in health care. In addition to his research, Etienne Minvielle is also advisor at Gustave Roussy, a leading European Cancer center, for implementing innovative patient pathways. He works closely with the CEO and the board of directors to help design innovative patient pathways
Day 3: Krzysztof Pyrć
Pandemic – Polish Perspective
Krzysztof Pyrć is a virologist. Graduated from Jagiellonian University (M.Sc.), University of Amsterdam (Ph.D.), and University of Lodz (habilitation). In January 2019 received the title of Professor in the field of biological sciences. He specializes in emerging RNA viruses (mainly coronaviruses and flaviviruses), with particular emphasis on mechanisms of infection and the development of new therapeutic strategies. Head of the Laboratory of Virology at the Malopolska Centre of Biotechnology, Jagiellonian University. A certified project manager. Leader of Virogenetics research group, supervisor, and promoter of students and Ph.D. students. Authored over 100 publications in journals as Nature Medicine, Science Translational Medicine, PNAS, PloS Pathogens, Journal of Virology, or Science Signaling, which have been cited nearly four thousand times in the world literature. Reviewer and expert in science funding institutions in Poland and abroad (Horizon2020, ERC, FNP, NCN, and others). Author of several patent applications and patents, on the basis of which 2 spin-off companies have already been established (Acatavir and StartIt Vet).
Manager and coordinator of numerous research grants, including under Horizon2020, IMI2, European Cooperation in Science and Technology, NCN, FNP, NCBIR, and MNiSW, as well as grants funded by commercial entities.
Member of the advisory team of the Minister of Science and Higher Education for activities related to the prevention, counteraction, and eradication of COVID-19. Deputy chairman of the advisory team (COVID-19) to the President of the Polish Academy of Sciences, member of the scientific board of the initiative Science against Pandemic. Member of the Medical Council to the Prime Minister. Expert of the Agency for Health Technology Assessment and Tarification – AOTMiT in the field of SARS-CoV-2 therapy and diagnostics.